Mitchell Clark edits Passive Monthly Income for Lombardi, and an ad of theirs this week promises great gains from “PRIP” investments… … so, naturally, we want to know what those are. Right? I don’t know if we want to subscribe to Passive Monthly Income or not, that’s one of dozens of newsletters published by Lombardi, […]
Articles
- Most Relevant
- Most Recent
Bob Czeschin edits a few newsletters, some of which look at really tiny mining and energy stocks, but the ad that has been coming through lately is for his relatively inexpensive Oil & Energy Investment Report that often looks at more mainstream investments, and it’s all about a breakthrough technology that he compares to getting […]
I like Frank Curzio’s podcast (now called Wall Street Unplugged), and I generally find his way of thinking interesting, so after he was laid off by Porter Stansberry I was half hoping he’d go off on his own and build his own newsletter business from scratch (he edited Phase 1 Investor and Small Cap Specialist […]
Just to be clear, when I include that “3-to-1 Gains Guaranteed” in the headline, that’s a quote from the ad — your friendly neighborhood Stock Gumshoe doesn’t guarantee anything, except that I’ll continue to do my best to dig into these fabulous teaser ads … you keep reading, I’ll keep writing, that’s the deal. Today’s […]
Before gold and silver started taking off a few months ago, lithium had been the only non-disappointing commodity investment around for quite a while… and we covered a bunch of teasers for lithium producers and explorers over the past year, most of which were built on the “Tesla’s gigafactory is going to need more lithium […]
ETF trading system.
It’s the end of the year, so we’re running into all those stories again about how this is the longest expansion in history, and we have never gone this long without seeing a 20% (or more) drop in the market. Which, of course, fires up the market timer in all of us — especially now […]
The “Internet of Things” is sure getting a lot of attention these days — most people throw around the forecasted numbers of $17-20 trillion as the market for this new technology, in which everything is interconnected and data is collected about you and your appliances and the roads you drive on and, well, everything. Even […]
This teaser came to my attention a couple days ago, it’s from Ian Wyatt for his Energy World Profits newsletter, which as far as I can tell is new — it at least hasn’t been covered in this space before. It’s a newsletter that he edits with Gregor Mcdonald, who apparently is an “energy economist,” […]
Sean Brodrick has a new ad out recruiting charter subscribers for his new Red-Hot Resource Millionaire newsletter ($2,500/yr), and in the ad he’s pitching a bunch of his favorite gold juniors. The questions are piling up here on the doorstep at Gumshoe HQ… so let’s see what we can find. As with most of these […]
No, this one’s not about you and your Uncle Bill. And it’s not about the little Gumshoes and their struggle with Algebra. It’s a headline from Frank Curzio, who earlier in the week sent out a hint-y email to at least a few folks that said, “How to capitalize on America’s most ‘stupid’ family.” It’s […]
Harris Kupperman is an international growth hedge fund manager who basically launched Mongolia Growth Group (YAK.V MNGGF) because he was looking for a way to invest in a trend that wasn’t really available. His talk wasn’t really so much about the company they’ve been building (and which I bought a few weeks ago), but about […]
Timothy Lutts doesn’t often send out really over-the-top out teaser ads, so I don’t often write about the various newsletters from Cabot — I do hear about them from time to time, and readers have reviewed a few of the services, but they haven’t yet bombarded us with “super hype” as so many other publishers […]
It’s been a very long time since I’ve looked at a teaser from the Motley Fool’s Hidden Gems service — that’s the “small cap value” newsletter which used to be run by Tom Gardner. It’s now edited by Andy Cross over at the Motley Fool, and has dropped some of the “value focus” but still […]
Well, Louis Navellier is nothing if not consistent — his ads always promise that a stock with recent huge earnings surprises is going to repeat, grow, and continue to delight investors. That’s the joy of being a trend follower — when you get it right. Of course, when you get it wrong with these fast-growth […]
Eric Roseman of the Sovereign Society has been blanketing the web with a teaser about a “different way to own gold” — one that he says might give you a discount of as much as $600 an ounce. Here’s what he says … “Recently, I’ve been researching different ways to own gold – and two months ago — I came across a little-known form of the yellow metal. The shocking thing is, it has outperformed “normal” gold investments by a factor of 10… or more!”
The latest pitch from Roadrunner Stocks starts out, as do many “small cap growth” and “breakout” stock newsletters, with the story of Monster Beverage (MNST) — the top stock of the last decade, and for many years the favorite idea of every momentum stock lover. And like the rest of us, Jim Fink at Roadrunner […]
The latest ads from Cabot’s Global Stocks Explorer caught my eye with a “bypass the coronavirus” pitch. Here’s how the ad starts: “Bypass the Coronavirus…with this hidden gem at the heart of ‘the biggest investment boom in history’ “Operating revenue increased over 70%. “Gross profit surged 122%. “Net income was up over 60%. “Total bookings […]
Healthcare-focused newsletter, recommended stocks primarily of emerging device and biotech companies. Was helmed by Marc Lichtenfeld, who moved on to other publications, but stopped publishing after a short while — Lightning Trend Trader, a current publication of Lichtenfeld’s with The Oxford Club, sometimes covers biotech stocks.
Sometimes a tease comes in as a heavy promo push, sometimes it’s a slightly more subtle pile of hints in a free article that gently suggests that you subscribe to their premium service … today’s item for sleuthification is the latter. Louis Basenese, who is pitching for the White Cap Report, wrote a free article […]
“Tesla is building the largest battery factory ever… “Groundbreaking is expected any day now. You could see… “GigaProfits! “It doesn’t matter what you think about electric cars… You could make a fortune off Tesla’s new $5 billion ‘Gigafactory’ — Even if it’s a colossal failure. “One tiny resource company is essential to the Gigafactory. Here’s […]
It’s like the Stansberry folks know what appeals to your friendly neighborhood Stock Gumshoe… and they just can’t get enough of our coverage. Every time I turn around lately they’re teasing and promoting a different kind of “royalty” company. And I loves me some royalties. Royalty companies are pretty well understood by most investors — […]
Anyone know which company he is pitching? Article: This ”$1 Dynamo” is Preparing to Tap 10 Bakken Oil Formations Here’s the one, tiny company — trading for $1.21 — about to crack open a gas jackpot worth upwards of $2 trillion … and why it could double your money by September, 2014 … and hand […]
That’s right, the end of obesity. That’s what’s being touted by the new letter that as far as I can tell was just launched moments ago by Agora, which they’re calling FDA Trader and for which they apparently hired away Paul Mampilly from the Palm Beach Letter (OK, they didn’t really “hire him away” — […]
Biotech trading advisory/newsletter, designed to make shorter-term trades around “catalyst” events, mostly in drug development (previously called FDA Trader when the publisher was still called Agora Financial, Blanco took over after previous editor Paul Mampilly left).
There have been two pretty big promo campaigns about the Alibaba IPO in the last week or so — one from Bill Patalon in an ad for his Private Briefing, and the other from Mike Palmer for Jeff Clark’s S&A Short Report… so I thought we should try to take a look, answer some reader […]
Before I get churning with this week’s Friday File, I want to take the opportunity to thank you, the Irregulars — and particularly the several new members we’ve had join up as Irregulars in the last few weeks — welcome to the club! Stock Gumshoe has always tried to balance how we do things, offering […]
POET Technologies Inc. (TSX.V:PTK): Disruptive Advances In Intel’s (NASDAQ:INTC) Back Yard Written By: James West|April 22, 2014 |Posted In: Top Stories POET Technologies Inc. (TSX.V:PTK) CEO Peter Copetti is charging his cell phone twice a day right now, and he’s working on holidays. Thats because his company, currently working in the same space as Intel […]
As of May 14, Leeb is also now pitching this as a major holding of the “other Oracle of Omaha”, though the rest of the ad is mostly unchanged… that’s a reference to fund manager Wally Weitz, who I mention more below and whose funds are large holders of the stock teased. Stephen Leeb has […]
Roadrunner Stocks is a newsletter run by Jim Fink at Investing Daily, and I think I’ve only covered his teaser pitches once before — that was back in October, and the four stocks he touted at the time are more or less a wash over that time period, half better performers than the market and […]
A hodgepodge of thoughts and comments to catch up with thoughts on a few companies that have reported quarterly results or had other meaningful news as I was on vacation — and a quick note on a small buy. First, I need to let you know that I bought a few JP Morgan warrants (JPM-WT) […]
Alan – We open here a forum for discussing options. It might be helpful to open the discussion with a copy of the paragraphs that I wrote 4/24 about options. I don’t know how to cut-and-paste that material. Before I opened this discussion forum, I noticed a question about choosing a stock that might perform […]
“What tangled webs we mortals weave when first we practice to deceive” – Shakespeare “There’s a sucker born every minute” – P.T. Barnum I know its been only a few days since my March article ran on these cyber-pages, but there is an issue currently unfolding in the market that simply may not wait until […]
Well, after spending last month catching up and revising my thoughts and opinions about the dozens of stocks I’ve covered for the Irregulars in this space, it’s time to again look for something interesting for your consideration. First, I should let you know that I’ve become less worried about about Seadrill (SDRL) this week after […]
I just watched a promo featuring subjects ”Survive & Prosper” and ”Income Extermination”. He pushes 3 income strategies that must be addressed ”immediately”. Is the Mighty Thinkolator up to discovering his secrets?
It’s fair to say that we get more than our share of teasers for commodity and natural resources stocks here at Stock Gumshoe — those kinds of stocks take up a big chunk of the newsletter world, with only tech stocks and biotech maybe keeping up. They’re areas where it’s easy to have (or pretend […]
[Ed. note: Here is the next exciting installment from Jim Skelton, the Blind Squirrel, who is sharing his experiences as a financial advisor with us. As with all of our contributors, the opinions he expresses are his own, and we haven’t reviewed, approved or screened his ideas. His previous articles can be seen here.] Greetings […]
I’ve been putting out my updated thoughts on each of our Irregulars spreadsheet companies (mostly past “Idea of the Month” stocks) over the last couple weeks, and now that I’m done looking at all of the “Speculations” on that list I thought I should combine them into one document to make it a bit easier […]
The Motley Fool gets more coverage here at Stock Gumshoe than pretty much any other newsletter publisher, with the possible exception of Stansberry — partly because the Fool has had some very good picks over the years, and partly because they have one of the biggest email lists around and they push a lot of […]
Apparently the world has royalties on the brain this week … or at least, the part of the world that lives in Florida and has worked for Porter Stansberry. Frank Curzio, who writes from northern Florida, I think, has been pushing for royalty stocks, most recently patent and pharmaceutical royalties, for his expensive Phase 1 […]